Pharmaceuticals,
Год журнала:
2023,
Номер
16(7), С. 1042 - 1042
Опубликована: Июль 22, 2023
Background
and
rationale.
The
therapeutic
interventions
against
lung
cancer
are
currently
based
on
a
fully
personalized
approach
to
the
disease
with
considerable
improvement
of
patients’
outcome.
Alongside
continuous
scientific
progresses
research
investments,
massive
technologic
efforts,
innovative
challenges,
consolidated
achievements
together
investments
at
bases
engineering
manufacturing
revolution
that
allows
significant
gain
in
clinical
setting.
Aim
methods.
scope
this
review
is
thus
focus,
rather
than
biologic
traits,
analysis
precision
sensors
novel
generation
materials,
as
semiconductors,
which
below
development
diagnosis
treatment.
In
perspective,
careful
revision
state
art
literature
experimental
knowledge
presented.
Results.
Novel
materials
being
used
treatment
for
cancer.
Among
them,
semiconductors
analyze
volatile
compounds
allow
early
diagnosis.
Moreover,
they
can
be
generate
MEMS
have
found
an
application
advanced
imaging
techniques
well
drug
delivery
devices.
Conclusions.
Overall,
these
issues
represent
critical
only
partially
known
generally
underestimated
by
community.
These
micro-technology-based
biosensing
devices,
use
molecules
atomic
concentrations,
crucial
innovation
since
allowed
recent
advances
biology
deciphering
detection
therapy.
There
urgent
need
create
stronger
dialogue
between
technologists,
basic
researchers,
clinicians
address
all
efforts
towards
real
Here,
great
attention
focused
their
cancer,
from
exploitations
translational
development,
ensure
better
outcomes.
Abstract
Medical
devices
play
a
crucial
role
in
modern
healthcare,
providing
innovative
solutions
for
diagnosing,
preventing,
monitoring,
and
treating
ailments.
Artificial
Intelligence
is
transforming
the
field
of
medical
devices,
offering
unprecedented
opportunities
through
diagnostic
accuracy,
personalized
treatment
plans,
enhancing
patient
outcomes.
This
review
outlines
applications
artificial
intelligence-based
healthcare
specialties,
especially
dentistry,
imaging,
ophthalmology,
mental
health,
autism
spectrum
disorder
diagnosis,
oncology,
general
medicine.
Specifically,
highlights
advancements
such
as
improved
tailored
planning,
enhanced
clinical
outcomes
above-mentioned
applications.
Regulatory
approval
remains
key
issue,
where
must
be
approved
or
cleared
by
United
States
Food
Drug
Administration
to
establish
their
safety
efficacy.
The
regulatory
guidance
pathway
presented
moreover
critical
technical,
ethical,
implementation
challenges
that
addressed
large-scale
adoption
are
discussed.
concludes
intersection
intelligence
with
device
domain
internet-enabled
technology,
biotechnology,
nanotechnology,
therapeutics,
enables
an
enormous
opportunity
accelerate
customized
patient-centered
care.
By
evaluating
these
challenges,
study
aims
present
insights
into
future
trajectory
smart
technologies
advancing
personalized,
Pharmaceuticals,
Год журнала:
2023,
Номер
16(7), С. 1042 - 1042
Опубликована: Июль 22, 2023
Background
and
rationale.
The
therapeutic
interventions
against
lung
cancer
are
currently
based
on
a
fully
personalized
approach
to
the
disease
with
considerable
improvement
of
patients’
outcome.
Alongside
continuous
scientific
progresses
research
investments,
massive
technologic
efforts,
innovative
challenges,
consolidated
achievements
together
investments
at
bases
engineering
manufacturing
revolution
that
allows
significant
gain
in
clinical
setting.
Aim
methods.
scope
this
review
is
thus
focus,
rather
than
biologic
traits,
analysis
precision
sensors
novel
generation
materials,
as
semiconductors,
which
below
development
diagnosis
treatment.
In
perspective,
careful
revision
state
art
literature
experimental
knowledge
presented.
Results.
Novel
materials
being
used
treatment
for
cancer.
Among
them,
semiconductors
analyze
volatile
compounds
allow
early
diagnosis.
Moreover,
they
can
be
generate
MEMS
have
found
an
application
advanced
imaging
techniques
well
drug
delivery
devices.
Conclusions.
Overall,
these
issues
represent
critical
only
partially
known
generally
underestimated
by
community.
These
micro-technology-based
biosensing
devices,
use
molecules
atomic
concentrations,
crucial
innovation
since
allowed
recent
advances
biology
deciphering
detection
therapy.
There
urgent
need
create
stronger
dialogue
between
technologists,
basic
researchers,
clinicians
address
all
efforts
towards
real
Here,
great
attention
focused
their
cancer,
from
exploitations
translational
development,
ensure
better
outcomes.
